Regulation of valvular interstitial cell calcification by components of the extracellular matrix

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 4, 2009, Pages 1043-1053

  Rodriguez, Karien J ^a   Masters, Kristyn S ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

Biomaterials; Calcification; Extracellular matrix; Valvular interstitial cells

Indexed keywords

ALKALINE PHOSPHATASE; APOPTOTIC; CALCIFICATION; COMPOSITION ANALYSIS; ECM COMPOSITION; ELEVATED LEVEL; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX; GROWTH FACTOR; HEART VALVE DISEASE; HEART VALVES; IN-VITRO; LAMININ; NECROTIC CELLS; NUMBER AND SIZE; TISSUE ENGINEERING SCAFFOLD; VALVULAR INTERSTITIAL CELLS; VIABLE CELLS;

BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMINERALIZATION; BONE; CALCIFICATION (BIOCHEMISTRY); CELL MEMBRANES; ELECTRIC DISCHARGE MACHINING; MATRIX ALGEBRA; MINERALOGY; POLYSACCHARIDES; PROFESSIONAL ASPECTS; TISSUE ENGINEERING;

CELL CULTURE;

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BIOMATERIAL; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; COLLAGEN; FIBRIN; FIBRONECTIN; HEPARIN; HYDROXYAPATITE; LAMININ; POLYSTYRENE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; AORTA VALVE; APOPTOSIS; ARTICLE; CELL; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MINERALIZATION; NONHUMAN; PROTEIN EXPRESSION; SCANNING ELECTROCHEMICAL MICROSCOPY; TISSUE ENGINEERING; VALVULAR INTERSTITIAL CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CALCINOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HEART VALVES; SWINE;

EID: 68249150571     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32187     Document Type: Article

References (40)

1. Mohler ER III. Mechanisms of aortic valve calcification. Am J Cardiol 2004;94:1396-1402.
2. Latif N, Sarathchandra P, Taylor PM, Antoniw J, Yacoub MH. Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis 2005;14:218-227.
3. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol 1996;12:231-236.
4. Flanagan TC, Black A, O'Brien M, Smith TJ, Pandit AS. Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis. Cell Tissue Organ 2006;183:12-23.
5. Gupta V, Werdenberg JA, Blevins TL, Grande-Allen KJ. Synthesis of glycosaminoglycans in differently loaded regions of collagen gels seeded with valvular interstitial cells. Tissue Eng 2007;13:41-49.
6. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. JHeartValveDis 2004;13:841-847.
7. Jian B, Narula N, Li QY, Mohler ER III, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003;75:457-465; discussion 465-466.
8. Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kilic R, Sarikoc A, Pinol R, Hagl S, Lang S, Brueckmann M, Borggrefe M. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-87.
9. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-411.
10. Cushing MC, Liao JT, Anseth KS. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. Matrix Biol 2005;24:428-437.
11. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: Implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004;95:253-260.
12. Kaden JJ, Kilic R, Sarikoc A, Hagl S, Lang S, Hoffmann U, Brueckmann M, Borggrefe M. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: A potential regulatory mechanism of valvular calcification. Int J Mol Med 2005;16:869-872.
13. Mathieu P, Voisine P, Pepin A, Shetty R, Savard N, Dagenais F. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis 2005;14:353-357.
14. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522.
15. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-2184.
16. Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997;99:996-1009.
17. Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006;98:1431-1438.
18. Williams C, Johnson SL, Robinson PS, Tranquillo RT. Cell sourcing and culture conditions for fibrin-based valve constructs. Tissue Eng 2006;12:1489-1502.
19. Cushing MC, Liao JT, Jaeggli MP, Anseth KS. Material-based regulation of the myofibroblast phenotype. Biomaterials 2007;28:3378-3387.
20. Bryant SJ, Durand KL, Anseth KS. Manipulations in hydrogel chemistry control photoencapsulated chondrocyte behavior and their extracellular matrix production. J Biomed Mater Res A 2003;67:1430-1436.
21. Johnson CM, Hanson MN, Helgeson SC. Porcine cardiac valvular subendothelial cells in culture: Cell isolation and growth characteristics. J Mol Cell Cardiol 1987;19:1185-1193.
22. Braet F, De Zanger R, Wisse E. Drying cells for SEM. AFM and TEM by hexamethyldisilazane: A study on hepatic endothelial cells. J Microsc 1997;186(Pt 1):84-87.
23. Mikroulis D, Mavrilas D, Kapolos J, Koutsoukos PG, Lolas C. Physicochemical and microscopical study of calcific deposits from natural and bioprosthetic heart valves. Comparison and implications for mineralization mechanism. J Mater Sci Mater Med 2002;13:885.
24. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-689.
25. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 2006;114(Suppl 1):I547-I552.
26. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006;260:192-210.
27. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998;18:1964-1971.
28. Yang L, Butcher M, Simon RR, Osip SL, Shaughnessy SG. The effect of heparin on osteoblast differentiation and activity in primary cultures of bovine aortic smooth muscle cells. Atherosclerosis 2005;179:79-86.
29. Fava RA, McClure DB. Fibronectin-associated transforming growth factor. J Cell Physiol 1987;131:184-189.
30. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-284.
31. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-1528.
32. Bini A, Mann KG, Kudryk BJ, Schoen FJ. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1852-1861.
33. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999;154:871-882.
34. Flanagan TC, Wilkins B, Black A, Jockenhoevel S, Smith TJ, Pandit AS. A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials 2006;27:2233-2246.
35. Masters KS, Mann BK. Tissue engineered heart. In: Nedovic V, Willaert R, editors. Applications of Cell Immobilisation Biotechnology. New York, NY: Kluwer; 2005.
36. Masters KS, Shah DN, Leinwand LA, Anseth KS. Cross-linked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 2005;26:2517-2525.
37. Masters KS, Shah DN, Walker G, Leinwand LA, Anseth KS. Designing scaffolds for valvular interstitial cells: Cell adhesion and function on naturally derived materials. J Biomed Mater Res A 2004;71:172-180.
38. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 2005;26:999-1010.
39. Taylor PM, Allen SP, Dreger SA, Yacoub MH. Human cardiac valve interstitial cells in collagen sponge: A biological three-dimensional matrix for tissue engineering. J Heart Valve Dis 2002;11:298-306.
40. Vesely I. Heart valve tissue engineering. Circ Res 2005;97:743-755.